Hisun Pharma: HSK47388 Clinical Trial Approved

On August 7th, Hisun Pharmaceutical announced that their HSK47388 tablet has recently been approved for clinical trials. The HSK47388 tablet is a orally administered, potent, and highly selective drug developed independently by the company, intended for the treatment of auto immune diseases. The development of innovative drugs has a long research and development cycle, multiple stages, and high risks, making it vulnerable to certain uncertainties.